Source: Health Canada shortage reports · Updated Oct 9, 2026
Some Metformin Sitagliptin products are in shortage in Canada (7 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A combination of two diabetes medications used to lower blood sugar in type 2 diabetes.
Products affected
7 / 23
In shortage since
Jul 22, 2025
Reports on file
73
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
1000MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 02520516 · since Jun 10, 2026, est. end Aug 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
850MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 02520508 · since Mar 10, 2026, est. end Aug 20, 2026 · Disruption of the manufacture of the drug.
DIN 02416808 · ended Sep 29, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Metformin Sitagliptin is currently affected by 7 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Metformin Sitagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).
Recent changes
Oct 9, 2026
Shortage resolved
Oct 6, 2026
Shortage resolved
Oct 2, 2026
Estimated end date pushed back : Oct 9, 2026 → Oct 16, 2026
Oct 2, 2026
Shortage resolved
Sep 28, 2026
Status changed
Sep 28, 2026
Shortage resolved
Sep 25, 2026
Estimated end date pushed back : Sep 25, 2026 → Oct 9, 2026
Sep 25, 2026
Estimated end date pushed back : Sep 25, 2026 → Oct 2, 2026
Sep 11, 2026
New report filed
Sep 4, 2026
New report filed
Aug 19, 2026
Status changed
Aug 19, 2026
Estimated end date pushed back : Sep 4, 2026 → Sep 18, 2026
Aug 18, 2026
Estimated end date pushed back : Sep 11, 2026 → Oct 9, 2026
Jul 31, 2026
Estimated end date pushed back : Jul 20, 2026 → Aug 20, 2026
Jul 31, 2026
Estimated end date pushed back : Jul 20, 2026 → Aug 20, 2026
Jul 24, 2026
Shortage resolved
Jul 16, 2026
Estimated end date pushed back : Jul 17, 2026 → Jul 24, 2026
Jul 16, 2026
Estimated end date pushed back : Jul 17, 2026 → Jul 31, 2026
Jul 10, 2026
New report filed
Jul 10, 2026
New report filed
Common questions
What is Metformin Sitagliptin used for?
A combination of two diabetes medications used to lower blood sugar in type 2 diabetes.
When will Metformin Sitagliptin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Metformin Sitagliptin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.